Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Imunon Inc IMNN

Healthcare Biotechnology
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the... see more

Recent & Breaking News (NDAQ:IMNN)

Free Research Reports on BIOF, CLSN, FTNT and SWKS Issued by the Bedford Report

Marketwired February 1, 2013

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Marketwired February 1, 2013

Law Firm Brower Piven Announces Investigation of Investor Securities Fraud Against Celsion Corporation

Business Wire January 31, 2013

Celsion Announces Results of Phase III HEAT Study of ThermoDox® in Primary Liver Cancer

PR Newswire January 31, 2013

Celsion Corporation to Host Conference Call and Webcast on January 31, 2013 at 8:00 AM EST to Present Top-Line Data from its Pivotal Phase III HEAT Study

PR Newswire January 30, 2013

Special Offer for Shareholders of TWO, CLSN, CIM and DDD

Marketwired January 28, 2013

The Straight Truth, Investing in CLSN, LINE, DDD and CLF

Marketwired January 25, 2013

Free Research Reports on T, CLSN, STX and KKD Issued by the Bedford Report

Marketwired January 23, 2013

The Real Story Behind TAGG, CLSN, and IMSC

Marketwired January 23, 2013

Celsion Corporation and Zhejiang Hisun Pharmaceutical Company Enter Into Technology Development Agreement for ThermoDox® for the Greater China Territory

PR Newswire January 22, 2013

Free Research Reports on AVEO, CLSN, PATH and VVUS Issued by the Bedford Report

Marketwired January 18, 2013

Free Research Reports on CLRO, CLSN, GSX and IRWD Issued by the Bedford Report

Marketwired January 17, 2013

Our Pros Knew CMVT, SHLD, CLSN and FLO Would Be Top Gainers on Monday

Marketwired January 15, 2013

Elite Traders Group Offers Insights on Biotech Industry Comparing It to the Next Computer Age

Marketwired January 14, 2013

Key to Success, How to Profit: CLSN, GALE, KERX and JAZZ

Marketwired January 11, 2013

Biotech Industry Expected to Experience More M&A Activity in 2013

Marketwired January 10, 2013

The Reason It Trades, What's Moving CLSN, ONXX, IMMU and NLNK

Marketwired January 10, 2013

Perfect Trade Setups, How to Play CLSN, GALE, KERX and JAZZ

Marketwired January 9, 2013

The Real Story Behind ZAGG, CLSN, YELP and BGMD

Marketwired January 8, 2013

Monday's Most Active -- RAD, GSS, CLSN and DCTH

Marketwired December 26, 2012